VAN HOUTE HANS (Chief Financial Officer) sold 14.3% of their position (6.28K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $78.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2025ACC: 0001817217-25-000005
Officer· Chief Financial Officer
Since Jul 2020
-6.28K
Net shares
Net seller
$78.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.28K
Price / share
$12.56
Trade value
$78.93K
% of position
14.3%
11/3/2025
43.88K→37.59K
Total
Net shares
−6.28K
Net value
-$78.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/3/2025 | S · Sale | −6.28K | $12.56 | $78.93K | 14.3% | 43.88K | 37.59K |
| Total | −6.28K | -$78.93K | ||||||
Derivative Transactions0
No derivative transactions reported